Rank | Gene Set | Z-score |
---|---|---|
1 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.70928586 |
2 | nuclear pore complex assembly (GO:0051292) | 4.52657483 |
3 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.38723681 |
4 | nuclear pore organization (GO:0006999) | 4.37156599 |
5 | regulation of RNA export from nucleus (GO:0046831) | 4.15274298 |
6 | histone H2A monoubiquitination (GO:0035518) | 4.08417567 |
7 | mitotic sister chromatid cohesion (GO:0007064) | 4.06097618 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.05978083 |
9 | actin-myosin filament sliding (GO:0033275) | 3.98763535 |
10 | muscle filament sliding (GO:0030049) | 3.98763535 |
11 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.96433803 |
12 | T-helper cell differentiation (GO:0042093) | 3.96433803 |
13 | positive regulation of granulocyte differentiation (GO:0030854) | 3.95287007 |
14 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94313451 |
15 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.77763989 |
16 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.77763989 |
17 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.76657701 |
18 | positive thymic T cell selection (GO:0045059) | 3.76047610 |
19 | mitotic chromosome condensation (GO:0007076) | 3.68245428 |
20 | skeletal muscle contraction (GO:0003009) | 3.66609018 |
21 | embryonic process involved in female pregnancy (GO:0060136) | 3.62915729 |
22 | skeletal muscle adaptation (GO:0043501) | 3.61380201 |
23 | mitotic metaphase plate congression (GO:0007080) | 3.60567482 |
24 | regulation of spindle organization (GO:0090224) | 3.57105371 |
25 | negative T cell selection (GO:0043383) | 3.55718626 |
26 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.54057220 |
27 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.53706763 |
28 | actin-mediated cell contraction (GO:0070252) | 3.53396770 |
29 | regulation of necroptotic process (GO:0060544) | 3.48666718 |
30 | negative regulation of necroptotic process (GO:0060546) | 3.44126430 |
31 | regulation of relaxation of muscle (GO:1901077) | 3.44090012 |
32 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.42289760 |
33 | negative thymic T cell selection (GO:0045060) | 3.39934180 |
34 | pore complex assembly (GO:0046931) | 3.38600150 |
35 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.33355616 |
36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33186951 |
37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.33186951 |
38 | actin filament-based movement (GO:0030048) | 3.30692721 |
39 | negative regulation of histone methylation (GO:0031061) | 3.26178316 |
40 | T cell differentiation involved in immune response (GO:0002292) | 3.25052687 |
41 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.25052687 |
42 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.25052687 |
43 | positive regulation of chromosome segregation (GO:0051984) | 3.24939233 |
44 | mitotic nuclear envelope disassembly (GO:0007077) | 3.24328056 |
45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.20936632 |
46 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.20766439 |
47 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18551208 |
48 | thymic T cell selection (GO:0045061) | 3.16919420 |
49 | regulation of podosome assembly (GO:0071801) | 3.16506943 |
50 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.16323568 |
51 | negative regulation of cell killing (GO:0031342) | 3.16323568 |
52 | hepatocyte apoptotic process (GO:0097284) | 3.11790673 |
53 | cellular response to arsenic-containing substance (GO:0071243) | 3.10661571 |
54 | DNA damage induced protein phosphorylation (GO:0006975) | 3.09028842 |
55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.06973994 |
56 | positive T cell selection (GO:0043368) | 3.04995792 |
57 | regulation of sister chromatid cohesion (GO:0007063) | 3.03257504 |
58 | metaphase plate congression (GO:0051310) | 3.02808629 |
59 | nuclear envelope disassembly (GO:0051081) | 3.02361696 |
60 | membrane disassembly (GO:0030397) | 3.02361696 |
61 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.01513733 |
62 | histone H2A ubiquitination (GO:0033522) | 3.00957737 |
63 | interferon-gamma production (GO:0032609) | 2.99521148 |
64 | protein localization to kinetochore (GO:0034501) | 2.99301668 |
65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99050468 |
66 | regulation of response to interferon-gamma (GO:0060330) | 2.98631504 |
67 | regulation of mitotic spindle organization (GO:0060236) | 2.96953348 |
68 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.96931265 |
69 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.95948226 |
70 | protein localization to chromosome, centromeric region (GO:0071459) | 2.95458000 |
71 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.95082595 |
72 | response to interleukin-15 (GO:0070672) | 2.93264956 |
73 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.92758104 |
74 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.92151160 |
75 | NIK/NF-kappaB signaling (GO:0038061) | 2.91012678 |
76 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.90933542 |
77 | cytokine production involved in immune response (GO:0002367) | 2.89808881 |
78 | histone mRNA catabolic process (GO:0071044) | 2.85348845 |
79 | folic acid metabolic process (GO:0046655) | 2.80522892 |
80 | T cell selection (GO:0045058) | 2.80237344 |
81 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.79715454 |
82 | response to muramyl dipeptide (GO:0032495) | 2.74753044 |
83 | regulation of granulocyte differentiation (GO:0030852) | 2.73869300 |
84 | striated muscle atrophy (GO:0014891) | 2.72365923 |
85 | establishment of chromosome localization (GO:0051303) | 2.71614057 |
86 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.71573774 |
87 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.70499754 |
88 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.69849559 |
89 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.68979073 |
90 | ribosome assembly (GO:0042255) | 2.66274445 |
91 | regulation of translational termination (GO:0006449) | 2.63943822 |
92 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.63826088 |
93 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.63812204 |
94 | protein localization to chromosome (GO:0034502) | 2.63293618 |
95 | regulation of histone H3-K27 methylation (GO:0061085) | 2.62560002 |
96 | histone H3-K36 demethylation (GO:0070544) | 2.62379225 |
97 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.62036365 |
98 | Rap protein signal transduction (GO:0032486) | 2.61220802 |
99 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.59706565 |
100 | response to laminar fluid shear stress (GO:0034616) | 2.59091304 |
101 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.58575857 |
102 | nuclear envelope organization (GO:0006998) | 2.58174127 |
103 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.57366002 |
104 | sarcomere organization (GO:0045214) | 2.57130001 |
105 | germinal center formation (GO:0002467) | 2.56947190 |
106 | pre-miRNA processing (GO:0031054) | 2.55478230 |
107 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.55375860 |
108 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.55375860 |
109 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.55375860 |
110 | dosage compensation (GO:0007549) | 2.55036489 |
111 | regulation of fibroblast apoptotic process (GO:2000269) | 2.54684581 |
112 | histone monoubiquitination (GO:0010390) | 2.54521505 |
113 | regulation of skeletal muscle contraction (GO:0014819) | 2.52448554 |
114 | T cell costimulation (GO:0031295) | 2.52404210 |
115 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.52207668 |
116 | cellular extravasation (GO:0045123) | 2.52183900 |
117 | myofibril assembly (GO:0030239) | 2.51873079 |
118 | muscle organ morphogenesis (GO:0048644) | 2.51374183 |
119 | cellular response to interleukin-15 (GO:0071350) | 2.51269353 |
120 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.50628967 |
121 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.49927941 |
122 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.49280017 |
123 | carnitine shuttle (GO:0006853) | 2.48827974 |
124 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.48604371 |
125 | lymphocyte costimulation (GO:0031294) | 2.47333662 |
126 | response to peptidoglycan (GO:0032494) | 2.46873869 |
127 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.45229973 |
128 | DNA replication checkpoint (GO:0000076) | 2.45206973 |
129 | regulation of immunoglobulin secretion (GO:0051023) | 2.44334661 |
130 | response to mercury ion (GO:0046689) | 2.44308105 |
131 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.44094622 |
132 | nerve growth factor signaling pathway (GO:0038180) | 2.43637619 |
133 | COPII vesicle coating (GO:0048208) | 2.43302336 |
134 | definitive hemopoiesis (GO:0060216) | 2.42900295 |
135 | protein K48-linked deubiquitination (GO:0071108) | 2.42829349 |
136 | necroptotic process (GO:0070266) | 2.41793633 |
137 | growth hormone receptor signaling pathway (GO:0060396) | 2.41426253 |
138 | regulation of histone H3-K9 methylation (GO:0051570) | 2.41028117 |
139 | mRNA modification (GO:0016556) | 2.40723275 |
140 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39861795 |
141 | corticosteroid receptor signaling pathway (GO:0031958) | 2.39238156 |
142 | protein localization to microtubule (GO:0035372) | 2.39121459 |
143 | sister chromatid cohesion (GO:0007062) | 2.38811765 |
144 | gonadal mesoderm development (GO:0007506) | 2.38780332 |
145 | tolerance induction (GO:0002507) | 2.38587936 |
146 | T cell lineage commitment (GO:0002360) | 2.38284439 |
147 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.36459296 |
148 | negative regulation of anoikis (GO:2000811) | 2.36379942 |
149 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.35605690 |
150 | T cell receptor signaling pathway (GO:0050852) | 2.35099449 |
151 | response to inactivity (GO:0014854) | 2.34604447 |
152 | muscle atrophy (GO:0014889) | 2.34364555 |
153 | regulation of RIG-I signaling pathway (GO:0039535) | 2.33679441 |
154 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.33445269 |
155 | positive regulation of B cell proliferation (GO:0030890) | 2.33147668 |
156 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.32624284 |
157 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.32531257 |
158 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.32528726 |
159 | T cell activation involved in immune response (GO:0002286) | 2.31989613 |
160 | B cell homeostasis (GO:0001782) | 2.31889154 |
161 | response to UV-C (GO:0010225) | 2.31391200 |
162 | positive regulation of interleukin-2 production (GO:0032743) | 2.30446539 |
163 | positive regulation of humoral immune response (GO:0002922) | 2.30416464 |
164 | production of molecular mediator of immune response (GO:0002440) | 2.30328451 |
165 | response to arsenic-containing substance (GO:0046685) | 2.28804233 |
166 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.28438861 |
167 | positive regulation of isotype switching (GO:0045830) | 2.28312969 |
168 | N-terminal protein amino acid acetylation (GO:0006474) | 2.28311172 |
169 | striated muscle contraction (GO:0006941) | 2.27894698 |
170 | negative regulation of necrotic cell death (GO:0060547) | 2.27700494 |
171 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.27380960 |
172 | hypotonic response (GO:0006971) | 2.26389305 |
173 | nucleobase biosynthetic process (GO:0046112) | 2.26027955 |
174 | protein K63-linked deubiquitination (GO:0070536) | 2.25717566 |
175 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.25068987 |
176 | NLS-bearing protein import into nucleus (GO:0006607) | 2.24600944 |
177 | histone lysine demethylation (GO:0070076) | 2.24472996 |
178 | T cell migration (GO:0072678) | 2.24464677 |
179 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.24183777 |
180 | protein K6-linked ubiquitination (GO:0085020) | 2.24089005 |
181 | chromatin assembly or disassembly (GO:0006333) | 2.23803832 |
182 | histone phosphorylation (GO:0016572) | 2.23175920 |
183 | regulation of chromosome segregation (GO:0051983) | 2.23082207 |
184 | carnitine transmembrane transport (GO:1902603) | 2.22896253 |
185 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.22673751 |
186 | DNA unwinding involved in DNA replication (GO:0006268) | 2.22623350 |
187 | response to muscle activity (GO:0014850) | 2.21805586 |
188 | regulation of necrotic cell death (GO:0010939) | 2.21546257 |
189 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.21223940 |
190 | detection of molecule of bacterial origin (GO:0032490) | 2.20756551 |
191 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.19746658 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.35417904 |
2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.92526484 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.51568947 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.35338595 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 3.25853973 |
6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.16521626 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.97913680 |
8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.65698229 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.65147837 |
10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.50265159 |
11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.38634331 |
12 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.36715338 |
13 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35172103 |
14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.19964441 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02397192 |
16 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.97920057 |
17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.95729932 |
18 | MYB_26560356_Chip-Seq_TH2_Human | 1.89028943 |
19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.88303784 |
20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.84371019 |
21 | MYB_26560356_Chip-Seq_TH1_Human | 1.83938133 |
22 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.83012701 |
23 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.81110504 |
24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.80314877 |
25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76996799 |
26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73763921 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73351457 |
28 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.73220254 |
29 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.71360551 |
30 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.71360551 |
31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.67744856 |
32 | MAF_26560356_Chip-Seq_TH1_Human | 1.65558107 |
33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.63255970 |
34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63100496 |
35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61458402 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60842051 |
37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58596255 |
38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.56992026 |
39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.56453292 |
40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56104277 |
41 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55895157 |
42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53093120 |
43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53024873 |
44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52002042 |
45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.51743819 |
46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.51743819 |
47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.49115476 |
48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.48790778 |
49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48612800 |
50 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48458531 |
51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46918310 |
52 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.46328112 |
53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45574847 |
54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.40921509 |
55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40467138 |
56 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.40370478 |
57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39783778 |
58 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39666837 |
59 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37625720 |
60 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.37603332 |
61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35244485 |
62 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.35143366 |
63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33294751 |
64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33246655 |
65 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33105987 |
66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.32887966 |
67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31713776 |
68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30695264 |
69 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29400662 |
70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28464203 |
71 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.28311651 |
72 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.28061650 |
73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27952310 |
74 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.26099576 |
75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26038107 |
76 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25403470 |
77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23794875 |
78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23403968 |
79 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.22815721 |
80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22664971 |
81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.22087415 |
82 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.21314951 |
83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19962155 |
84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19791412 |
85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19543693 |
86 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19047961 |
87 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17572984 |
88 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.15863473 |
89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15643348 |
90 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.15141848 |
91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15131220 |
92 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.14988073 |
93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14725143 |
94 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13936582 |
95 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12643347 |
96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11649395 |
97 | MAF_26560356_Chip-Seq_TH2_Human | 1.10819156 |
98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10251285 |
99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09599566 |
100 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.09358452 |
101 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07181510 |
102 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07181510 |
103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07111011 |
104 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06720025 |
105 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06382039 |
106 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06247681 |
107 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05627015 |
108 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05615353 |
109 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.04991457 |
110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04979421 |
111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04635743 |
112 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04579424 |
113 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04571171 |
114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03491824 |
115 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03430006 |
116 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02942439 |
117 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02126446 |
118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01938619 |
119 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01783154 |
120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01083629 |
121 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00996994 |
122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00781931 |
123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00390074 |
124 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00252719 |
125 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00155107 |
126 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00054997 |
127 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99676809 |
128 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98753138 |
129 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98178117 |
130 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.98086314 |
131 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97990764 |
132 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97307469 |
133 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97147508 |
134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96032851 |
135 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95708701 |
136 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94640801 |
137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94126472 |
138 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93694154 |
139 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93482022 |
140 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93263237 |
141 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92907136 |
142 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92783568 |
143 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92230904 |
144 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.91847826 |
145 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91603794 |
146 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.90634373 |
147 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.90557553 |
148 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90449216 |
149 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90413237 |
150 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89990180 |
151 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89638397 |
152 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89297623 |
153 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88956001 |
154 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.88586248 |
155 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.88246260 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 3.20432532 |
2 | MP0008057_abnormal_DNA_replication | 3.01592278 |
3 | MP0003693_abnormal_embryo_hatching | 2.57858665 |
4 | MP0003646_muscle_fatigue | 2.53775743 |
5 | MP0003077_abnormal_cell_cycle | 2.48279405 |
6 | MP0010094_abnormal_chromosome_stability | 2.48150095 |
7 | MP0003828_pulmonary_edema | 2.36912304 |
8 | MP0002332_abnormal_exercise_endurance | 2.36484329 |
9 | MP0003111_abnormal_nucleus_morphology | 2.31280450 |
10 | MP0010352_gastrointestinal_tract_polyps | 2.20203951 |
11 | MP0002396_abnormal_hematopoietic_system | 2.17214951 |
12 | MP0000749_muscle_degeneration | 2.17192900 |
13 | MP0001800_abnormal_humoral_immune | 2.16076351 |
14 | MP0010307_abnormal_tumor_latency | 2.08802091 |
15 | MP0004145_abnormal_muscle_electrophysio | 2.05511514 |
16 | MP0000685_abnormal_immune_system | 2.04724161 |
17 | MP0002166_altered_tumor_susceptibility | 2.03360458 |
18 | MP0004957_abnormal_blastocyst_morpholog | 1.99102318 |
19 | MP0005671_abnormal_response_to | 1.96519128 |
20 | MP0004233_abnormal_muscle_weight | 1.95136201 |
21 | MP0004036_abnormal_muscle_relaxation | 1.92118957 |
22 | MP0002398_abnormal_bone_marrow | 1.92077140 |
23 | MP0003191_abnormal_cellular_cholesterol | 1.90203884 |
24 | MP0004808_abnormal_hematopoietic_stem | 1.82038369 |
25 | MP0003303_peritoneal_inflammation | 1.80900209 |
26 | MP0003950_abnormal_plasma_membrane | 1.80843414 |
27 | MP0005451_abnormal_body_composition | 1.79060348 |
28 | MP0003300_gastrointestinal_ulcer | 1.79039194 |
29 | MP0001730_embryonic_growth_arrest | 1.76017845 |
30 | MP0009333_abnormal_splenocyte_physiolog | 1.74293645 |
31 | MP0002006_tumorigenesis | 1.72792891 |
32 | MP0008007_abnormal_cellular_replicative | 1.72144049 |
33 | MP0004087_abnormal_muscle_fiber | 1.70541530 |
34 | MP0009840_abnormal_foam_cell | 1.69670480 |
35 | MP0000689_abnormal_spleen_morphology | 1.68291362 |
36 | MP0000703_abnormal_thymus_morphology | 1.67528983 |
37 | MP0002723_abnormal_immune_serum | 1.64092117 |
38 | MP0004185_abnormal_adipocyte_glucose | 1.62838764 |
39 | MP0002405_respiratory_system_inflammati | 1.62788913 |
40 | MP0000759_abnormal_skeletal_muscle | 1.62556063 |
41 | MP0002452_abnormal_antigen_presenting | 1.62310339 |
42 | MP0001790_abnormal_immune_system | 1.61398525 |
43 | MP0005387_immune_system_phenotype | 1.61398525 |
44 | MP0004484_altered_response_of | 1.59423956 |
45 | MP0002420_abnormal_adaptive_immunity | 1.59384564 |
46 | MP0002722_abnormal_immune_system | 1.58413597 |
47 | MP0000716_abnormal_immune_system | 1.56141909 |
48 | MP0005076_abnormal_cell_differentiation | 1.56077614 |
49 | MP0001819_abnormal_immune_cell | 1.55780153 |
50 | MP0005397_hematopoietic_system_phenotyp | 1.52952543 |
51 | MP0001545_abnormal_hematopoietic_system | 1.52952543 |
52 | MP0005365_abnormal_bile_salt | 1.52675851 |
53 | MP0001835_abnormal_antigen_presentation | 1.52513572 |
54 | MP0003436_decreased_susceptibility_to | 1.52290091 |
55 | MP0000350_abnormal_cell_proliferation | 1.52236286 |
56 | MP0000013_abnormal_adipose_tissue | 1.52013597 |
57 | MP0002139_abnormal_hepatobiliary_system | 1.51927332 |
58 | MP0000747_muscle_weakness | 1.50984425 |
59 | MP0005000_abnormal_immune_tolerance | 1.50857283 |
60 | MP0004947_skin_inflammation | 1.49967553 |
61 | MP0008058_abnormal_DNA_repair | 1.47653838 |
62 | MP0004084_abnormal_cardiac_muscle | 1.47211556 |
63 | MP0001873_stomach_inflammation | 1.46651786 |
64 | MP0003091_abnormal_cell_migration | 1.45856033 |
65 | MP0002106_abnormal_muscle_physiology | 1.44706911 |
66 | MP0000751_myopathy | 1.44559080 |
67 | MP0010678_abnormal_skin_adnexa | 1.40854308 |
68 | MP0000733_abnormal_muscle_development | 1.39784980 |
69 | MP0002269_muscular_atrophy | 1.39380829 |
70 | MP0005310_abnormal_salivary_gland | 1.37722922 |
71 | MP0002019_abnormal_tumor_incidence | 1.37038232 |
72 | MP0002009_preneoplasia | 1.36959145 |
73 | MP0005360_urolithiasis | 1.35836656 |
74 | MP0000609_abnormal_liver_physiology | 1.34189000 |
75 | MP0002429_abnormal_blood_cell | 1.33727786 |
76 | MP0004130_abnormal_muscle_cell | 1.28433632 |
77 | MP0003705_abnormal_hypodermis_morpholog | 1.27851018 |
78 | MP0010155_abnormal_intestine_physiology | 1.27768014 |
79 | MP0010234_abnormal_vibrissa_follicle | 1.26996380 |
80 | MP0003252_abnormal_bile_duct | 1.25858713 |
81 | MP0005380_embryogenesis_phenotype | 1.25487588 |
82 | MP0001672_abnormal_embryogenesis/_devel | 1.25487588 |
83 | MP0002971_abnormal_brown_adipose | 1.21171582 |
84 | MP0003984_embryonic_growth_retardation | 1.19380363 |
85 | MP0003656_abnormal_erythrocyte_physiolo | 1.18111215 |
86 | MP0002088_abnormal_embryonic_growth/wei | 1.17936330 |
87 | MP0002086_abnormal_extraembryonic_tissu | 1.16167671 |
88 | MP0000490_abnormal_crypts_of | 1.15849688 |
89 | MP0005620_abnormal_muscle_contractility | 1.14853068 |
90 | MP0000465_gastrointestinal_hemorrhage | 1.12883296 |
91 | MP0009115_abnormal_fat_cell | 1.12809593 |
92 | MP0009278_abnormal_bone_marrow | 1.12725014 |
93 | MP0001845_abnormal_inflammatory_respons | 1.12119033 |
94 | MP0003718_maternal_effect | 1.10508064 |
95 | MP0001697_abnormal_embryo_size | 1.09481925 |
96 | MP0005025_abnormal_response_to | 1.06776826 |
97 | MP0002138_abnormal_hepatobiliary_system | 1.06564335 |
98 | MP0001853_heart_inflammation | 1.06260108 |
99 | MP0003724_increased_susceptibility_to | 1.04809118 |
100 | MP0005330_cardiomyopathy | 1.04756757 |
101 | MP0002419_abnormal_innate_immunity | 1.03979383 |
102 | MP0002972_abnormal_cardiac_muscle | 1.03684545 |
103 | MP0010630_abnormal_cardiac_muscle | 1.03248911 |
104 | MP0002877_abnormal_melanocyte_morpholog | 1.01697200 |
105 | MP0005369_muscle_phenotype | 1.00911579 |
106 | MP0002796_impaired_skin_barrier | 1.00869912 |
107 | MP0008877_abnormal_DNA_methylation | 1.00637726 |
108 | MP0001348_abnormal_lacrimal_gland | 0.99963656 |
109 | MP0006082_CNS_inflammation | 0.99682894 |
110 | MP0003806_abnormal_nucleotide_metabolis | 0.98531317 |
111 | MP0003183_abnormal_peptide_metabolism | 0.98350174 |
112 | MP0003045_fibrosis | 0.97148052 |
113 | MP0005621_abnormal_cell_physiology | 0.94411862 |
114 | MP0003448_altered_tumor_morphology | 0.93171195 |
115 | MP0004264_abnormal_extraembryonic_tissu | 0.92919934 |
116 | MP0009785_altered_susceptibility_to | 0.92673347 |
117 | MP0005166_decreased_susceptibility_to | 0.92565220 |
118 | MP0005023_abnormal_wound_healing | 0.92112361 |
119 | MP0000750_abnormal_muscle_regeneration | 0.91927356 |
120 | MP0002080_prenatal_lethality | 0.91777131 |
121 | MP0005085_abnormal_gallbladder_physiolo | 0.88934457 |
122 | MP0006138_congestive_heart_failure | 0.88730300 |
123 | MP0001851_eye_inflammation | 0.88547062 |
124 | MP0003866_abnormal_defecation | 0.85485258 |
125 | MP0000383_abnormal_hair_follicle | 0.84769551 |
126 | MP0002084_abnormal_developmental_patter | 0.84139509 |
127 | MP0000003_abnormal_adipose_tissue | 0.83450101 |
128 | MP0000598_abnormal_liver_morphology | 0.82872529 |
129 | MP0002085_abnormal_embryonic_tissue | 0.82803225 |
130 | MP0000313_abnormal_cell_death | 0.82316718 |
131 | MP0004510_myositis | 0.82236302 |
132 | MP0005375_adipose_tissue_phenotype | 0.82187489 |
133 | MP0001191_abnormal_skin_condition | 0.81687713 |
134 | MP0001915_intracranial_hemorrhage | 0.81644165 |
135 | MP0005266_abnormal_metabolism | 0.81245944 |
136 | MP0000858_altered_metastatic_potential | 0.80411734 |
137 | MP0005501_abnormal_skin_physiology | 0.79680810 |
138 | MP0002933_joint_inflammation | 0.79487440 |
139 | MP0003453_abnormal_keratinocyte_physiol | 0.79226130 |
140 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78466846 |
141 | MP0005666_abnormal_adipose_tissue | 0.77941697 |
142 | MP0001533_abnormal_skeleton_physiology | 0.77880704 |
143 | MP0004197_abnormal_fetal_growth/weight/ | 0.77836549 |
144 | MP0001216_abnormal_epidermal_layer | 0.76652599 |
145 | MP0008961_abnormal_basal_metabolism | 0.73786933 |
146 | MP0002998_abnormal_bone_remodeling | 0.71506806 |
147 | MP0003868_abnormal_feces_composition | 0.71279711 |
148 | MP0002127_abnormal_cardiovascular_syste | 0.69645047 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 7.17355040 |
2 | Nemaline bodies (HP:0003798) | 7.01906924 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.96352314 |
4 | Exercise-induced myalgia (HP:0003738) | 5.60689467 |
5 | Exercise-induced muscle cramps (HP:0003710) | 4.64507569 |
6 | Type 1 muscle fiber predominance (HP:0003803) | 4.64058886 |
7 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.51217070 |
8 | Subaortic stenosis (HP:0001682) | 4.51217070 |
9 | EMG: myopathic abnormalities (HP:0003458) | 4.08044646 |
10 | T lymphocytopenia (HP:0005403) | 4.04523570 |
11 | Abnormality of T cell number (HP:0011839) | 3.81495788 |
12 | Abnormality of the fingertips (HP:0001211) | 3.79256788 |
13 | Difficulty running (HP:0009046) | 3.75293287 |
14 | Hyporeflexia of lower limbs (HP:0002600) | 3.63868106 |
15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.44200748 |
16 | Birth length less than 3rd percentile (HP:0003561) | 3.40432414 |
17 | Combined immunodeficiency (HP:0005387) | 3.37153224 |
18 | Muscle fiber splitting (HP:0003555) | 3.35229835 |
19 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.27590646 |
20 | Severe combined immunodeficiency (HP:0004430) | 3.26153826 |
21 | Calf muscle hypertrophy (HP:0008981) | 3.24961507 |
22 | Recurrent viral infections (HP:0004429) | 3.20606108 |
23 | Rhabdomyolysis (HP:0003201) | 3.13695620 |
24 | Myoglobinuria (HP:0002913) | 3.06226386 |
25 | Distal arthrogryposis (HP:0005684) | 3.02309840 |
26 | Abnormality of the calf musculature (HP:0001430) | 3.01533853 |
27 | Neck muscle weakness (HP:0000467) | 2.97317721 |
28 | Myopathic facies (HP:0002058) | 2.95489605 |
29 | Myocardial infarction (HP:0001658) | 2.95460546 |
30 | Abnormality of T cells (HP:0002843) | 2.93335746 |
31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.92606376 |
32 | Thyroiditis (HP:0100646) | 2.86428458 |
33 | Recurrent fungal infections (HP:0002841) | 2.82405570 |
34 | Rimmed vacuoles (HP:0003805) | 2.81512245 |
35 | IgG deficiency (HP:0004315) | 2.72357386 |
36 | Facial hemangioma (HP:0000329) | 2.70971292 |
37 | Entropion (HP:0000621) | 2.69354516 |
38 | Subacute progressive viral hepatitis (HP:0006572) | 2.66743496 |
39 | IgM deficiency (HP:0002850) | 2.62692315 |
40 | Stomatitis (HP:0010280) | 2.62026127 |
41 | Increased connective tissue (HP:0009025) | 2.61676177 |
42 | Curly hair (HP:0002212) | 2.61217061 |
43 | Small epiphyses (HP:0010585) | 2.59450061 |
44 | Areflexia of lower limbs (HP:0002522) | 2.59339747 |
45 | Hyperkalemia (HP:0002153) | 2.55693192 |
46 | Pelvic girdle muscle weakness (HP:0003749) | 2.54678553 |
47 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.54019623 |
48 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.54019623 |
49 | Gastrointestinal infarctions (HP:0005244) | 2.53834675 |
50 | Frequent falls (HP:0002359) | 2.52035016 |
51 | Panhypogammaglobulinemia (HP:0003139) | 2.51307372 |
52 | Overlapping toe (HP:0001845) | 2.49965016 |
53 | Papillary thyroid carcinoma (HP:0002895) | 2.47497961 |
54 | Increased variability in muscle fiber diameter (HP:0003557) | 2.42025735 |
55 | Distal lower limb muscle weakness (HP:0009053) | 2.41880814 |
56 | Asymmetric septal hypertrophy (HP:0001670) | 2.41680625 |
57 | Abnormality of B cell number (HP:0010975) | 2.41497525 |
58 | B lymphocytopenia (HP:0010976) | 2.41497525 |
59 | Pustule (HP:0200039) | 2.38800975 |
60 | Recurrent bronchitis (HP:0002837) | 2.38503448 |
61 | Progressive muscle weakness (HP:0003323) | 2.37034738 |
62 | Acute myeloid leukemia (HP:0004808) | 2.37007216 |
63 | Tetraparesis (HP:0002273) | 2.35521926 |
64 | Leukocytosis (HP:0001974) | 2.33286158 |
65 | Distal lower limb amyotrophy (HP:0008944) | 2.33283751 |
66 | Bundle branch block (HP:0011710) | 2.32685919 |
67 | Thrombocytosis (HP:0001894) | 2.29393521 |
68 | Polycythemia (HP:0001901) | 2.29060343 |
69 | IgA deficiency (HP:0002720) | 2.26089546 |
70 | Abnormality of eosinophils (HP:0001879) | 2.25651042 |
71 | Deep philtrum (HP:0002002) | 2.24801465 |
72 | Increased density of long bones (HP:0006392) | 2.21951400 |
73 | Ulnar deviation of the wrist (HP:0003049) | 2.19079851 |
74 | Malignant hyperthermia (HP:0002047) | 2.18089036 |
75 | EMG: neuropathic changes (HP:0003445) | 2.18076654 |
76 | Fatigue (HP:0012378) | 2.17800063 |
77 | Eosinophilia (HP:0001880) | 2.15929767 |
78 | Volvulus (HP:0002580) | 2.15266245 |
79 | Dysmetric saccades (HP:0000641) | 2.14695548 |
80 | Arterial thrombosis (HP:0004420) | 2.14215818 |
81 | Hematochezia (HP:0002573) | 2.13273085 |
82 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11830895 |
83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11830895 |
84 | Abnormality of T cell physiology (HP:0011840) | 2.10253551 |
85 | Breast hypoplasia (HP:0003187) | 2.09839316 |
86 | Sparse lateral eyebrow (HP:0005338) | 2.08083265 |
87 | Irregular epiphyses (HP:0010582) | 2.07087313 |
88 | Autoimmune hemolytic anemia (HP:0001890) | 2.06278123 |
89 | Hypoplasia of the thymus (HP:0000778) | 2.05128440 |
90 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.05077302 |
91 | Carpal bone hypoplasia (HP:0001498) | 2.04450164 |
92 | Long clavicles (HP:0000890) | 2.03876111 |
93 | Shoulder girdle muscle weakness (HP:0003547) | 2.03219055 |
94 | Autoimmune thrombocytopenia (HP:0001973) | 1.99594587 |
95 | Lymphoma (HP:0002665) | 1.98630210 |
96 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97961571 |
97 | Prominent nose (HP:0000448) | 1.97908261 |
98 | Lymphopenia (HP:0001888) | 1.97486844 |
99 | Lower limb hyperreflexia (HP:0002395) | 1.97388144 |
100 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.96437252 |
101 | Round ear (HP:0100830) | 1.96079303 |
102 | Spontaneous hematomas (HP:0007420) | 1.96005149 |
103 | Basal cell carcinoma (HP:0002671) | 1.94857817 |
104 | Chronic diarrhea (HP:0002028) | 1.94204747 |
105 | Progressive external ophthalmoplegia (HP:0000590) | 1.89279945 |
106 | Exocrine pancreatic insufficiency (HP:0001738) | 1.89140029 |
107 | Capillary hemangiomas (HP:0005306) | 1.88930910 |
108 | Heterotopia (HP:0002282) | 1.88556594 |
109 | Encephalitis (HP:0002383) | 1.88495183 |
110 | Deep venous thrombosis (HP:0002625) | 1.86898099 |
111 | Cystic hygroma (HP:0000476) | 1.86856448 |
112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.86415612 |
113 | Limb-girdle muscle atrophy (HP:0003797) | 1.86284259 |
114 | Eczematoid dermatitis (HP:0000976) | 1.85272960 |
115 | Multiple enchondromatosis (HP:0005701) | 1.85252286 |
116 | Muscular dystrophy (HP:0003560) | 1.85207718 |
117 | Abnormality of lateral ventricle (HP:0030047) | 1.85084637 |
118 | Abnormality of the prostate (HP:0008775) | 1.83584288 |
119 | Abnormal foot bone ossification (HP:0010675) | 1.81304158 |
120 | Myositis (HP:0100614) | 1.81096321 |
121 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80262798 |
122 | Osteolytic defects of the hand bones (HP:0009699) | 1.80262798 |
123 | Increased CSF protein (HP:0002922) | 1.80237500 |
124 | Impulsivity (HP:0100710) | 1.80165361 |
125 | Chromsome breakage (HP:0040012) | 1.79669551 |
126 | Delayed puberty (HP:0000823) | 1.79563764 |
127 | Sandal gap (HP:0001852) | 1.78833576 |
128 | Chronic otitis media (HP:0000389) | 1.78324049 |
129 | Optic neuritis (HP:0100653) | 1.78268369 |
130 | Retrobulbar optic neuritis (HP:0100654) | 1.78268369 |
131 | Hypobetalipoproteinemia (HP:0003563) | 1.76688739 |
132 | Viral hepatitis (HP:0006562) | 1.74772284 |
133 | Peritonitis (HP:0002586) | 1.74763292 |
134 | Proximal amyotrophy (HP:0007126) | 1.74592079 |
135 | Myelodysplasia (HP:0002863) | 1.74545449 |
136 | Abnormality of chromosome stability (HP:0003220) | 1.74502490 |
137 | Persistence of primary teeth (HP:0006335) | 1.74035619 |
138 | Slow saccadic eye movements (HP:0000514) | 1.73915836 |
139 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.72122898 |
140 | Facial diplegia (HP:0001349) | 1.71671608 |
141 | Dilated cardiomyopathy (HP:0001644) | 1.70389482 |
142 | Broad palm (HP:0001169) | 1.70311218 |
143 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.70065032 |
144 | Granulocytopenia (HP:0001913) | 1.69869116 |
145 | Cone-rod dystrophy (HP:0000548) | 1.69599989 |
146 | Oligodactyly (hands) (HP:0001180) | 1.69592223 |
147 | Abnormality of the peritoneum (HP:0002585) | 1.68178378 |
148 | Absent phalangeal crease (HP:0006109) | 1.67607138 |
149 | Patellar aplasia (HP:0006443) | 1.67567638 |
150 | Hyperglycinemia (HP:0002154) | 1.67278583 |
151 | Thickened calvaria (HP:0002684) | 1.66933437 |
152 | Cortical dysplasia (HP:0002539) | 1.66214742 |
153 | Cellulitis (HP:0100658) | 1.66211542 |
154 | Long eyelashes (HP:0000527) | 1.66205285 |
155 | Abnormal finger flexion creases (HP:0006143) | 1.66102405 |
156 | Pulmonary embolism (HP:0002204) | 1.65963939 |
157 | Esophageal varix (HP:0002040) | 1.65593144 |
158 | Thyroid carcinoma (HP:0002890) | 1.65480993 |
159 | Verrucae (HP:0200043) | 1.65153537 |
160 | Papilloma (HP:0012740) | 1.65153537 |
161 | Cutaneous melanoma (HP:0012056) | 1.64339077 |
162 | Toxemia of pregnancy (HP:0100603) | 1.63919740 |
163 | Amaurosis fugax (HP:0100576) | 1.62579725 |
164 | Keratoconjunctivitis sicca (HP:0001097) | 1.62022247 |
165 | Truncal obesity (HP:0001956) | 1.61634216 |
166 | Gingival bleeding (HP:0000225) | 1.61279795 |
167 | Scapular winging (HP:0003691) | 1.60791344 |
168 | Paralysis (HP:0003470) | 1.60356535 |
169 | Bulbar palsy (HP:0001283) | 1.59844667 |
170 | Hypochromic microcytic anemia (HP:0004840) | 1.59471776 |
171 | Thrombophlebitis (HP:0004418) | 1.59252464 |
172 | Nasal polyposis (HP:0100582) | 1.59008080 |
173 | Sudden death (HP:0001699) | 1.58363302 |
174 | Generalized muscle weakness (HP:0003324) | 1.57019437 |
175 | Muscle stiffness (HP:0003552) | 1.56269798 |
176 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.54021296 |
177 | Syringomyelia (HP:0003396) | 1.53620173 |
178 | Spinal cord lesions (HP:0100561) | 1.53620173 |
179 | Biliary tract neoplasm (HP:0100574) | 1.53295253 |
180 | Colitis (HP:0002583) | 1.51485318 |
181 | Poikilocytosis (HP:0004447) | 1.49468075 |
182 | Abnormality of nail color (HP:0100643) | 1.49359982 |
183 | Abnormality of the endocardium (HP:0004306) | 1.47923904 |
184 | Malnutrition (HP:0004395) | 1.46416589 |
185 | Hyperglycemia (HP:0003074) | 1.45641640 |
186 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.44831599 |
187 | Limb-girdle muscle weakness (HP:0003325) | 1.44156163 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 4.93244738 |
2 | MAP4K1 | 3.75885980 |
3 | PRPF4B | 3.29052580 |
4 | EEF2K | 3.27735209 |
5 | PIK3CG | 3.10864418 |
6 | TTN | 2.93262604 |
7 | LATS1 | 2.62745809 |
8 | CDK12 | 2.51072121 |
9 | JAK3 | 2.47647104 |
10 | STK10 | 2.44419351 |
11 | NEK2 | 2.30060406 |
12 | TXK | 2.29073107 |
13 | EIF2AK3 | 2.27881000 |
14 | SIK3 | 2.18702558 |
15 | TYK2 | 2.14230630 |
16 | FGFR4 | 2.05229874 |
17 | MAP3K10 | 2.02239770 |
18 | TAOK2 | 2.02235472 |
19 | CDC7 | 2.01958771 |
20 | AKT3 | 1.97065281 |
21 | PBK | 1.92678770 |
22 | TRPM7 | 1.81074351 |
23 | TAOK3 | 1.80812899 |
24 | PKN2 | 1.78438349 |
25 | ITK | 1.70877210 |
26 | EPHA3 | 1.68608054 |
27 | BMPR2 | 1.66987395 |
28 | STK3 | 1.63005492 |
29 | TAOK1 | 1.59756436 |
30 | IRAK1 | 1.52080747 |
31 | IRAK4 | 1.51872205 |
32 | SCYL2 | 1.51818642 |
33 | MELK | 1.50966893 |
34 | PIM1 | 1.49503220 |
35 | SGK3 | 1.48723628 |
36 | FGFR3 | 1.47859172 |
37 | CDK4 | 1.46292112 |
38 | SGK2 | 1.46064018 |
39 | PHKG2 | 1.46016815 |
40 | PHKG1 | 1.46016815 |
41 | MAP3K8 | 1.44876543 |
42 | WEE1 | 1.42914247 |
43 | GRK6 | 1.42409266 |
44 | NLK | 1.41291180 |
45 | STK24 | 1.40864125 |
46 | TRIB3 | 1.39767253 |
47 | JAK1 | 1.34579176 |
48 | IKBKE | 1.32217784 |
49 | CDK9 | 1.26212579 |
50 | MAP3K3 | 1.23602608 |
51 | BRSK2 | 1.21567065 |
52 | MAP3K5 | 1.19206794 |
53 | ZAP70 | 1.17569475 |
54 | ERBB3 | 1.14898329 |
55 | BRD4 | 1.13180635 |
56 | RPS6KA4 | 1.09999353 |
57 | NEK9 | 1.09966930 |
58 | MAP3K1 | 1.08615159 |
59 | PLK4 | 1.07979767 |
60 | MAP2K3 | 1.05324864 |
61 | TTK | 1.04956848 |
62 | MAP3K14 | 1.04238626 |
63 | CHUK | 1.03713465 |
64 | JAK2 | 1.02973400 |
65 | PIK3CA | 1.02881149 |
66 | MARK3 | 1.01941898 |
67 | EPHB1 | 1.01661256 |
68 | ACVR1B | 1.00880368 |
69 | TNIK | 1.00388706 |
70 | CDK6 | 0.98901058 |
71 | STK4 | 0.96726046 |
72 | KSR1 | 0.96348085 |
73 | LATS2 | 0.96286506 |
74 | IRAK2 | 0.96193140 |
75 | RPS6KB2 | 0.94891259 |
76 | MST1R | 0.94325675 |
77 | TSSK6 | 0.94294902 |
78 | IRAK3 | 0.94033574 |
79 | TEC | 0.93949347 |
80 | MAP3K2 | 0.92700490 |
81 | YES1 | 0.90307328 |
82 | IKBKB | 0.90193275 |
83 | MAP3K13 | 0.89687832 |
84 | CHEK2 | 0.89310157 |
85 | MST4 | 0.86803496 |
86 | CSK | 0.83661717 |
87 | FLT3 | 0.82261188 |
88 | MAP3K7 | 0.81691549 |
89 | MAPK7 | 0.81631075 |
90 | DYRK1B | 0.81254886 |
91 | RAF1 | 0.80739529 |
92 | ERBB4 | 0.78960881 |
93 | LCK | 0.77919441 |
94 | BUB1 | 0.77545970 |
95 | CHEK1 | 0.77016371 |
96 | AURKB | 0.76562164 |
97 | MAPK12 | 0.74159787 |
98 | ALK | 0.73677491 |
99 | ATR | 0.73371642 |
100 | HCK | 0.72641538 |
101 | STK38L | 0.72299415 |
102 | PLK1 | 0.71489014 |
103 | BTK | 0.69428758 |
104 | MAPK11 | 0.69418703 |
105 | TGFBR2 | 0.68554636 |
106 | EPHA2 | 0.68464537 |
107 | DYRK3 | 0.68024517 |
108 | LRRK2 | 0.67419086 |
109 | BCR | 0.67313740 |
110 | CDK19 | 0.67007540 |
111 | MTOR | 0.66906286 |
112 | TYRO3 | 0.66200593 |
113 | PDGFRB | 0.63313511 |
114 | RPS6KA5 | 0.62723900 |
115 | WNK1 | 0.61787763 |
116 | ATM | 0.61763627 |
117 | PASK | 0.61731793 |
118 | CDK7 | 0.60895759 |
119 | NEK6 | 0.60803263 |
120 | SIK1 | 0.58096491 |
121 | TBK1 | 0.56557291 |
122 | MOS | 0.56432433 |
123 | SRPK1 | 0.55025578 |
124 | MAPKAPK3 | 0.53828392 |
125 | MAP3K6 | 0.52579831 |
126 | KSR2 | 0.51722061 |
127 | MET | 0.51613517 |
128 | PLK3 | 0.50816643 |
129 | DMPK | 0.50416184 |
130 | RPS6KB1 | 0.49876559 |
131 | PRKCQ | 0.49694755 |
132 | PRKAA1 | 0.49262158 |
133 | TRIM28 | 0.48814680 |
134 | KIT | 0.48582006 |
135 | CDK2 | 0.48125087 |
136 | CSF1R | 0.47252305 |
137 | RIPK1 | 0.46908631 |
138 | SGK494 | 0.46246095 |
139 | SGK223 | 0.46246095 |
140 | PDK1 | 0.46122260 |
141 | ICK | 0.44902170 |
142 | AKT2 | 0.44429006 |
143 | ERN1 | 0.44321845 |
144 | PRKAA2 | 0.43873323 |
145 | CSNK1G1 | 0.43547534 |
146 | HIPK2 | 0.42907063 |
147 | TGFBR1 | 0.42106810 |
148 | NME2 | 0.42014225 |
149 | ABL1 | 0.41768943 |
150 | CAMKK2 | 0.41288087 |
151 | EIF2AK1 | 0.40002963 |
152 | CAMK1D | 0.39570131 |
153 | MAP3K11 | 0.39316927 |
154 | CSNK1D | 0.39256641 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.82750009 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.63494629 |
3 | Cell cycle_Homo sapiens_hsa04110 | 2.26294015 |
4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.13977299 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00809254 |
6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.97302832 |
7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.92125160 |
8 | RNA transport_Homo sapiens_hsa03013 | 1.89937468 |
9 | Measles_Homo sapiens_hsa05162 | 1.68392847 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68126812 |
11 | Endometrial cancer_Homo sapiens_hsa05213 | 1.65129114 |
12 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.60172968 |
13 | RNA degradation_Homo sapiens_hsa03018 | 1.54611419 |
14 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.52727939 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51510592 |
16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51338321 |
17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46879051 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45530152 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38415835 |
20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.36050594 |
21 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.35671703 |
22 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.31437224 |
23 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.29535490 |
24 | RNA polymerase_Homo sapiens_hsa03020 | 1.28288700 |
25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28001690 |
26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.26899968 |
27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26771339 |
28 | Hepatitis B_Homo sapiens_hsa05161 | 1.23742757 |
29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22994470 |
30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22637282 |
31 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.21392262 |
32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20949511 |
33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20839268 |
34 | Spliceosome_Homo sapiens_hsa03040 | 1.19920380 |
35 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.19765123 |
36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18610220 |
37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.16370402 |
38 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.14299876 |
39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.14252231 |
40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12246722 |
41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11851403 |
42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11061214 |
43 | DNA replication_Homo sapiens_hsa03030 | 1.08926041 |
44 | Basal transcription factors_Homo sapiens_hsa03022 | 1.07942939 |
45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06812646 |
46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05856101 |
47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.05775739 |
48 | Glioma_Homo sapiens_hsa05214 | 1.03992510 |
49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03185540 |
50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01631930 |
51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01385028 |
52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.00930489 |
53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00827328 |
54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99125694 |
55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98387760 |
56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97531116 |
57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97258224 |
58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.96710814 |
59 | Base excision repair_Homo sapiens_hsa03410 | 0.95470908 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.94745067 |
61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.94717402 |
62 | Bladder cancer_Homo sapiens_hsa05219 | 0.92330497 |
63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92258657 |
64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90595901 |
65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89291604 |
66 | Apoptosis_Homo sapiens_hsa04210 | 0.89280361 |
67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88493746 |
68 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.88360466 |
69 | Influenza A_Homo sapiens_hsa05164 | 0.87544179 |
70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86925583 |
71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86884733 |
72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85043893 |
73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83681881 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.83634194 |
75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83145238 |
76 | Tuberculosis_Homo sapiens_hsa05152 | 0.83091354 |
77 | Asthma_Homo sapiens_hsa05310 | 0.83020113 |
78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83018417 |
79 | Insulin resistance_Homo sapiens_hsa04931 | 0.82870534 |
80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82462083 |
81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.81651440 |
82 | Prostate cancer_Homo sapiens_hsa05215 | 0.81512974 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80157739 |
84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79816492 |
85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79775336 |
86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79148213 |
87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78634012 |
88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.75517210 |
89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75493680 |
90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75059724 |
91 | Malaria_Homo sapiens_hsa05144 | 0.74257136 |
92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.74223139 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74193286 |
94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73343037 |
95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72548534 |
96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72069008 |
97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71513073 |
98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71474971 |
99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71182568 |
100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70899101 |
101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69176896 |
102 | Allograft rejection_Homo sapiens_hsa05330 | 0.68303505 |
103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67797528 |
104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67500664 |
105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66803345 |
106 | Focal adhesion_Homo sapiens_hsa04510 | 0.65269610 |
107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64607337 |
108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64471795 |
109 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64389639 |
110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64084528 |
111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63915616 |
112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63442825 |
113 | Mismatch repair_Homo sapiens_hsa03430 | 0.62686102 |
114 | Legionellosis_Homo sapiens_hsa05134 | 0.61517886 |
115 | Hepatitis C_Homo sapiens_hsa05160 | 0.60856113 |
116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58596666 |
117 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58466614 |
118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58392430 |
119 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58372471 |
120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57480344 |
121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56854719 |
122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56768931 |
123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55802738 |
124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54784652 |
125 | Homologous recombination_Homo sapiens_hsa03440 | 0.54320336 |
126 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52291195 |
127 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51719426 |
128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51432441 |
129 | Shigellosis_Homo sapiens_hsa05131 | 0.51396134 |
130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51213205 |
131 | Amoebiasis_Homo sapiens_hsa05146 | 0.51118559 |
132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50132386 |
133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49351340 |
134 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.48462409 |
135 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47097798 |
136 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46272867 |
137 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46208246 |
138 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46030607 |
139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45023309 |
140 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.43587515 |
141 | Adherens junction_Homo sapiens_hsa04520 | 0.43103804 |
142 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41805272 |
143 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41630599 |